Emergency Department Interventions Cut Opioid Rx Rates
THURSDAY, Jan. 20, 2022 (HealthDay News) -- Most emergency department interventions aimed at cutting opioid prescribing cut the prescription rate but not the prescribed opioid quantity, according to a review published online Jan. 13 in JAMA Network Open.
Raoul Daoust, M.D., from Le Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île de-Montréal, and colleagues conducted a systematic literature review to identify intervention studies aimed at reducing opioid prescriptions at emergency department discharge.
Based on 45 studies included in the meta-analysis, the researchers found a statistically significant reduction in the opioid prescription rate for both interrupted time series (ITS; six-month step change, −22.61 percent) and other study designs (odds ratio, 0.56). ITS studies showed no significant reduction in prescribed opioid quantities (six-month step change, −8.64 percent), but there was a small, significant reduction in other study designs (standardized mean difference, −0.30). Education, policies, and guideline interventions were better at reducing the opioid prescription rate in ITS studies (six-month step change, −33.31 percent) versus prescription drug monitoring programs and laws (six-month step change, −11.18 percent). Prescribed opioid quantities were not reduced by most intervention categories.
"Novel interventions are needed to reduce the quantity of opioids per prescription by emergency department physicians while evaluating their associations with patient-centered outcomes," the authors write.
Related Posts
Eight in 10 Seniors See Wisdom of Dementia Screening
THURSDAY, July 20, 2023 (HealthDay News) -- Most older adults think that...
Providers, Patients Differ in Satisfaction With Anesthesia for Eye Surgery
WEDNESDAY, April 27, 2022 (HealthDay News) -- There is a low level of...
Sciatica: What Is It, and How Can You Ease the Pain?
MONDAY, June 26, 2023 (HealthDay News) -- If you have had a sharp pain shooting...
Opioids Can Be Continued in Cancer Patients With Nonmedical Stimulant Use
MONDAY, Sept. 11, 2023 (HealthDay News) -- For patients with cancer-related pain...